ENvue Medical Inc. (NASDAQ:FEED) — Market Cap & Net Worth
Market Cap & Net Worth: ENvue Medical Inc. (FEED)
ENvue Medical Inc. (NASDAQ:FEED) has a market capitalization of $369.49K ($369.49K) as of October 9, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #31144 globally and #6294 in its home market, demonstrating a 30.21% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ENvue Medical Inc.'s stock price $0.40 by its total outstanding shares 923717 (923.72K).
ENvue Medical Inc. Market Cap History: 2026 to 2026
ENvue Medical Inc.'s market capitalization history from 2026 to 2026. Data shows growth from $369.49K to $369.49K (0.00% CAGR). Check ENvue Medical Inc. (FEED) share price today for real-time trading data and today's change.
ENvue Medical Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ENvue Medical Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see cash efficiency ratio of ENvue Medical Inc. for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of FEED by Market Capitalization
Companies near ENvue Medical Inc. in the global market cap rankings as of October 9, 2026. See ENvue Medical Inc. (FEED) net asset quality to understand what proportion of total assets are financed by equity.
Key companies related to ENvue Medical Inc. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #133 globally with a market cap of $171.26 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #233 globally with a market cap of $106.24 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #133 | Abbott Laboratories | NYSE:ABT | $171.26 Billion | $98.49 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $87.75 |
| #233 | Stryker Corporation | NYSE:SYK | $106.24 Billion | $276.97 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
ENvue Medical Inc. Historical Marketcap From 2026 to 2026
Between 2026 and today, ENvue Medical Inc.'s market cap moved from $369.49K to $ 369.49K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $369.49K | -- |
End of Day Market Cap According to Different Sources
On Oct 9th, 2026 the market cap of ENvue Medical Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $369.49K USD |
| MoneyControl | $369.49K USD |
| MarketWatch | $369.49K USD |
| marketcap.company | $369.49K USD |
| Reuters | $369.49K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ENvue Medical Inc.
ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance. Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, incre… Read more